Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

May 31, 1995

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions
LeukemiaLymphomaMyelodysplastic Syndromes
Interventions
BIOLOGICAL

filgrastim

DRUG

cyclophosphamide

DRUG

cyclosporine

DRUG

cytarabine

DRUG

methotrexate

DRUG

methylprednisolone

PROCEDURE

allogeneic bone marrow transplantation

PROCEDURE

in vitro-treated bone marrow transplantation

RADIATION

radiation therapy

Trial Locations (13)

10021

Memorial Sloan-Kettering Cancer Center, New York

15224

Western Pennsylvania Hospital, Pittsburgh

27710

Duke Comprehensive Cancer Center, Durham

29203

University of South Carolina School of Medicine, Columbia

43210

Arthur G. James Cancer Hospital - Ohio State University, Columbus

52242

University of Iowa Hospitals and Clinics, Iowa City

53226

Midwest Children's Cancer Center, Milwaukee

55455

University of Minnesota Medical School, Minneapolis

84132

Huntsman Cancer Institute, Salt Lake City

94305-5408

Stanford University Medical Center, Stanford

40536-0084

Albert B. Chandler Medical Center, University of Kentucky, Lexington

27157-1082

Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem

23298-0037

Massey Cancer Center, Richmond

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Virginia Commonwealth University

OTHER